What's up in

Interviews & Opinions

QnA

Pharma Warning Letters Explained by Ipca’s Regulatory Affairs Head

FT - Dr. Shuvankar Ballav | August 9, 2025 |

QnA

Former GSK Director on What It Really Takes to Lead in Pharma

FT - Mr. Shyam Khante | August 4, 2025 |

QnA

How a Bench Chemist Built a Disruptive Pharma Startup

FT - Kimberly Lupo | August 4, 2025 |

QnA

What It Takes to Train 2,500 Medical Reps at GSK: A Deep Dive into the Journey of GSK's L&D Head

FT - Dr. Pankaj  Gursahani | August 1, 2025 |

QnA

A Leader Without Ego: Dr. Mithilesh Trivedi’s Pharma Journey

FT - Dr. Mithilesh Trivedi | July 27, 2025 |

QnA

How This Quality Leader Transformed Struggling Pharma Plants into Global-Ready Facilities

FT - Mr. Mahesh Saini | July 22, 2025 |

Discover Mr. Saini's journey from academia to crisis recovery in pharma—insights on ownership, compl...

QnA

What Makes a Good Trainer? Lessons from FDC’s L&D Head

FT - Mr. Rajesh Bhattacharjee | July 17, 2025 |

Rajesh Bhattacharjee shares how he built a global pharma training ecosystem at FDC, shaping minds be...

QnA

Regulatory Affairs Decoded: Insights from Biocon’s Varma Bhupathiraju

FT - Mr. Varma Bhupathiraju | July 4, 2025 |

Varma Bhupathiraju on the evolving role of Regulatory Affairs, biosimilars, and India’s global pharm...

QnA

Batch Destruction Over Risk: Why Quality Always Wins Biological E's Vice President

FT - Mr. Rakesh Kumar Sinha | June 28, 2025 |

Discover Rakesh Kumar Sinha's insights on quality, leadership, and operational excellence in pharma ...